Torthaí cuardaigh - Pchejetski, Dmitri
- 1 - 16 toradh as 16 á dtaispeáint
-
1
Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target de réir Alshaker, Heba, Thrower, Hannah, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2020Téacs -
2
Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting de réir Alshaker, Heba, Wang, Qi, Brewer, Daniel, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2019Téacs -
3
-
4
-
5
The emerging role of FTY720 (Fingolimod) in cancer treatment de réir White, Christopher, Alshaker, Heba, Cooper, Colin, Winkler, Matthias, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2016Téacs -
6
An unusual case of disseminated intravascular coagulation de réir Pchejetski, Dmitri, Kenbaz, Mojiba, Alshaker, Heba, Rajput, Dharmesh, Jesudason, Kiruparajan
Foilsithe / Cruthaithe 2017Téacs -
7
Dynamic early identification of hip replacement implants with high revision rates. Study based on the NJR data from UK during 2004-2012 de réir Begun, Alexander, MacGregor, Alexander J., Pchejetski, Dmitri, Kulinskaya, Elena
Foilsithe / Cruthaithe 2020Téacs -
8
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer de réir Pchejetski, Dmitri, Alfraidi, Albandri, Sacco, Keith, Alshaker, Heba, Muhammad, Aun, Monzon, Leonardo
Foilsithe / Cruthaithe 2015Téacs -
9
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth de réir Alshaker, Heba, Wang, Qi, Srivats, Shyam, Chao, Yimin, Cooper, Colin, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2017Téacs -
10
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer de réir Wang, Qi, Alshaker, Heba, Böhler, Torsten, Srivats, Shyam, Chao, Yimin, Cooper, Colin, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2017Téacs -
11
Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors de réir Alshaker, Heba, Srivats, Shyam, Monteil, Danielle, Wang, Qi, Low, Caroline M. R., Pchejetski, Dmitri
Foilsithe / Cruthaithe 2018Téacs -
12
Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer de réir Sacco, Keith, Muhammad, Aun, Saleem, Waqar, Alshaker, Heba, Monzon, Leonardo, Islam, Mohammad Rafiqul, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2016Téacs -
13
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1 de réir Alshaker, Heba, Wang, Qi, Kawano, Yoshiaki, Arafat, Tawfiq, Böhler, Torsten, Winkler, Mathias, Cooper, Colin, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2016Téacs -
14
Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1 de réir Alshaker, Heba, Wang, Qi, Böhler, Torsten, Mills, Robert, Winkler, Mathias, Arafat, Tawfiq, Kawano, Yoshiaki, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2017Téacs -
15
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway de réir Alshaker, Heba, Krell, Jonathan, Frampton, Adam E, Waxman, Jonathan, Blyuss, Oleg, Zaikin, Alexey, Winkler, Mathias, Stebbing, Justin, Yagüe, Ernesto, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2014Téacs -
16
Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups de réir Alshaker, Heba, Mills, Robert, Hunter, Ewan, Salter, Matthew, Ramadass, Aroul, Skinner, Benjamin Matthew, Westra, Willem, Green, Jayne, Akoulitchev, Alexandre, Winkler, Mathias, Pchejetski, Dmitri
Foilsithe / Cruthaithe 2021Téacs